301688.SZ
C格林生物
SZSE · C 制造业 · CN
CNY 41.19
Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.1B | 1.1B | 960.6M | 734.8M | 631.3M |
| Cost of Revenue | — | 733.5M | 675.3M | 542.0M | 484.6M |
| Gross Profit | — | 341.4M | 285.3M | 192.8M | 146.7M |
| Operating Expenses | |||||
| R&D Expense | — | 37.3M | 26.2M | 18.5M | 14.8M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | — | 51.8M | 51.9M | 39.0M | 29.2M |
| Selling & Marketing Expense | — | 8.4M | 6.9M | 6.1M | 6.9M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | — | 131.7M | 106.6M | 84.0M | 61.3M |
| Cost and Expenses | — | 865.2M | 781.9M | 626.0M | 545.9M |
| Operating Income (EBIT) | 114.6M | 206.5M | 176.3M | 105.1M | 76.4M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 114.6M | 206.3M | 173.1M | 105.1M | 74.9M |
| Income Tax Expense | — | 27.3M | 22.7M | 12.2M | 6.8M |
| Bottom Line | |||||
| Net Income | 182.9M | 179.0M | 150.4M | 92.9M | 68.1M |
| Earnings from Cont. Ops | — | 179.0M | 150.4M | 92.9M | 68.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 182.9M | 179.0M | 150.4M | 92.9M | 68.1M |
| Per Share | |||||
| Basic EPS | CN¥0.84 | CN¥1.79 | CN¥1.50 | CN¥0.93 | CN¥0.68 |
| Diluted EPS | CN¥0.84 | CN¥1.79 | CN¥1.50 | CN¥0.93 | CN¥0.68 |
| Revenue Per Share | CN¥11.41 | CN¥10.75 | CN¥9.58 | CN¥7.35 | CN¥6.30 |
| Shares | |||||
| Basic Shares Outstanding | 99.5M | 100.0M | 100.3M | 99.9M | 100.2M |
| Diluted Shares Outstanding | 99.5M | 100.0M | 100.3M | 99.9M | 100.2M |
| Profitability Metrics | |||||
| EBITDA | — | 282.2M | 237.5M | 147.4M | 117.1M |
| D&A | — | 75.7M | 61.1M | 42.3M | 40.7M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026